Biotech Updates

In response to U.S. President Joseph Biden's Executive Order 14081, “Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy,” the U.S. Environmental Protection Agency (EPA), U.S. Food and Drug Administration (FDA), and U.S. Department of Agriculture (USDA) developed a plan to update, streamline and clarify their regulations and oversight mechanisms for products of biotechnology.

ISAAA and Partners Discuss Regulatory Path to Commercialization of Biotech Products

ISAAA Inc., in partnership with the Philippine Agriculture and Fisheries Biotechnology Program of the Department of Agriculture (DA Biotech) and the Committee of Food Security of the House of Representatives, held a virtual policy forum on Regulatory Path to Commercialization of Biotech Products on May 9, 2024, via Zoom.

Regulatory Barriers Delay Adoption of Gene Editing Technologies

Gene editing is an emerging modern biotechnology technique that significantly influences farming systems, resulting in high-yielding farm inputs. However, regulatory burdens create barriers to the development and adoption of such technologies. In a paper written by Graham Brookes and Stuart J. Smyth, a risk-appropriate and evidence-based regulatory environment is examined for facilitating the adoption of gene editing technology.